Roivant Sciences Ltd. (ROIV)
32.41
+4.20
(+14.89%)
USD |
NASDAQ |
May 20, 16:00
32.35
-0.06
(-0.19%)
After-Hours: 20:00
Roivant Sciences EPS Diluted (Quarterly) : -0.3816 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 0.8693 |
| Moderna, Inc. | -3.40 |
| Centessa Pharmaceuticals Plc | -0.5152 |
| Silence Therapeutics Plc | -0.1055 |
| Adaptimmune Therapeutics Plc | -0.1163 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -313.70M |
| Revenue (Quarterly) | 1.999M |
| Total Expenses (Quarterly) | 267.89M |
| Enterprise Value | 16.47B |
| Gross Profit Margin (Quarterly) | 30.42% |
| Profit Margin (Quarterly) | -15.69K% |
| Earnings Yield | -3.61% |
| Normalized Earnings Yield | -3.952 |